{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:46:42Z","timestamp":1790416002714,"version":"4.1.0"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutr Rev"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1111\/nure.12084","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T18:28:55Z","timestamp":1386959335000},"page":"18-29","source":"Crossref","is-referenced-by-count":109,"title":["Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets"],"prefix":"10.1093","volume":"72","author":[{"given":"Douglas B","family":"DiRienzo","sequence":"first","affiliation":[{"name":"Quadrant Nutrition, LLC; Hendersonville North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,12,13]]},"reference":[{"key":"10.1111\/nure.12084-BIB0001|nure12084-cit-0001","unstructured":"World Health Organization, World Heart Federation, World Stroke Organization Global atlas on cardiovascular disease prevention and control http:\/\/www.who.int\/cardiovascular_diseases\/publications\/atlas_cvd\/en\/index.html"},{"key":"10.1111\/nure.12084-BIB0002|nure12084-cit-0002","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics - 2012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation."},{"key":"10.1111\/nure.12084-BIB0003|nure12084-cit-0003","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation."},{"key":"10.1111\/nure.12084-BIB0004|nure12084-cit-0004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation."},{"key":"10.1111\/nure.12084-BIB0005|nure12084-cit-0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.106.176158","article-title":"Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee","volume":"114","author":"Lichtenstein","year":"2006","journal-title":"Circulation."},{"key":"10.1111\/nure.12084-BIB0006|nure12084-cit-0006","unstructured":"World Health Organization Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk http:\/\/www.who.int\/cardiovascular_diseases\/publications\/Prevention_of_Cardiovascular_Disease\/en\/index.html"},{"key":"10.1111\/nure.12084-BIB0007|nure12084-cit-0007","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2672.2006.02963.x","article-title":"Probiotics and their fermented food products are beneficial for health","volume":"100","author":"Parvez","year":"2006","journal-title":"J Appl Microbiol."},{"key":"10.1111\/nure.12084-BIB0008|nure12084-cit-0008","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.107.720300","article-title":"Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention","volume":"117","author":"Grundy","year":"2008","journal-title":"Circulation."},{"key":"10.1111\/nure.12084-BIB0009|nure12084-cit-0009","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet."},{"key":"10.1111\/nure.12084-BIB0010|nure12084-cit-0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jada.2007.10.050","article-title":"The evidence for dietary prevention and treatment of cardiovascular disease","volume":"108","author":"Van Horn","year":"2008","journal-title":"J Am Diet Assoc."},{"key":"10.1111\/nure.12084-BIB0011|nure12084-cit-0011","unstructured":"Joint FAO\/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria Health and Nutritonal Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria Geneva World Health Organization 2001"},{"key":"10.1111\/nure.12084-BIB0012|nure12084-cit-0012","first-page":"1","article-title":"Probiotics, prebiotics, and synbiotics","volume":"111","author":"Vrese","year":"2008","journal-title":"Adv Biochem Eng Biotechnol."},{"key":"10.1111\/nure.12084-BIB0013|nure12084-cit-0013","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1017\/S0029665110001813","article-title":"Gut microbiota in obesity and metabolic disorders","volume":"69","author":"Sanz","year":"2010","journal-title":"Proc Nutr Soc."},{"key":"10.1111\/nure.12084-BIB0014|nure12084-cit-0014","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1753-4887.2011.00402.x","article-title":"Human gut microbiota and its relationship to health and disease","volume":"69","author":"Wallace","year":"2011","journal-title":"Nutr Rev."},{"key":"10.1111\/nure.12084-BIB0015|nure12084-cit-0015","unstructured":"Joint FAO\/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food Guidelines for the Evaluation of Probiotics in Food Geneva World Health Organization 2002"},{"key":"10.1111\/nure.12084-BIB0016|nure12084-cit-0016","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ajcn\/13.3.135","article-title":"Serum lipids in three nomadic tribes of northern Kenya","volume":"13","author":"Shaper","year":"1963","journal-title":"Am J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0017|nure12084-cit-0017","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/ajcn\/27.5.464","article-title":"Studies of a surfactant and cholesteremia in the Maasai","volume":"27","author":"Mann","year":"1974","journal-title":"Am J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0018|nure12084-cit-0018","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.numecd.2011.04.008","article-title":"Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials","volume":"21","author":"Guo","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"10.1111\/nure.12084-BIB0019|nure12084-cit-0019","first-page":"346","article-title":"Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men","volume":"49","author":"Agerbaek","year":"1995","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0020|nure12084-cit-0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/07315724.1999.10718826","article-title":"Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans","volume":"18","author":"Anderson","year":"1999","journal-title":"J Am Coll Nutr."},{"key":"10.1111\/nure.12084-BIB0021|nure12084-cit-0021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.ejcn.1600683","article-title":"Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia","volume":"53","author":"Bertolami","year":"1999","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0022|nure12084-cit-0022","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.ejcn.1600722","article-title":"Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels","volume":"53","author":"De Roos","year":"1999","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0023|nure12084-cit-0023","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.ejcn.1600937","article-title":"Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases","volume":"54","author":"Agerholm-Larsen","year":"2000","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0024|nure12084-cit-0024","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/ajcn\/76.6.1249","article-title":"Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers","volume":"76","author":"Naruszewicz","year":"2002","journal-title":"Am J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0025|nure12084-cit-0025","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3168\/jds.S0022-0302(03)73839-9","article-title":"Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers","volume":"86","author":"Xiao","year":"2003","journal-title":"J Dairy Sci."},{"key":"10.1111\/nure.12084-BIB0026|nure12084-cit-0026","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000094304","article-title":"Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women","volume":"50","author":"Fabian","year":"2006","journal-title":"Ann Nutr Metab."},{"key":"10.1111\/nure.12084-BIB0027|nure12084-cit-0027","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.numecd.2005.10.009","article-title":"Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol","volume":"16","author":"Simons","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"10.1111\/nure.12084-BIB0028|nure12084-cit-0028","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000203284","article-title":"Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects","volume":"54","author":"Ataie-Jafari","year":"2009","journal-title":"Ann Nutr Metab."},{"key":"10.1111\/nure.12084-BIB0029|nure12084-cit-0029","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1017\/S0007114509993801","article-title":"The effects of probiotic and conventional yoghurt on lipid profile in women","volume":"103","author":"Sadrzadeh-Yeganeh","year":"2010","journal-title":"Br J Nutr."},{"key":"10.1111\/nure.12084-BIB0030|nure12084-cit-0030","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.ejcn.1601104","article-title":"The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies","volume":"54","author":"Agerholm-Larsen","year":"2000","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0031|nure12084-cit-0031","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1017\/S0007114511004703","article-title":"Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults","volume":"107","author":"Jones","year":"2012","journal-title":"Br J Nutr."},{"key":"10.1111\/nure.12084-BIB0032|nure12084-cit-0032","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ejcn.2012.126","article-title":"Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial","volume":"66","author":"Jones","year":"2012","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0033|nure12084-cit-0033","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.3168\/jds.2010-4128","article-title":"Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus","volume":"94","author":"Ejtahed","year":"2011","journal-title":"J Dairy Sci."},{"key":"10.1111\/nure.12084-BIB0034|nure12084-cit-0034","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.3168\/jds.2010-3311","article-title":"Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters","volume":"93","author":"Ooi","year":"2010","journal-title":"J Dairy Sci."},{"key":"10.1111\/nure.12084-BIB0035|nure12084-cit-0035","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.ejcn.1600583","article-title":"Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers","volume":"52","author":"Schaafsma","year":"1998","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0036|nure12084-cit-0036","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.fct.2012.03.010","article-title":"Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study","volume":"50","author":"Jones","year":"2012","journal-title":"Food Chem Toxicol."},{"key":"10.1111\/nure.12084-BIB0037|nure12084-cit-0037","first-page":"15","volume-title":"Functional Foods: the Consumer, the Product and the Evidence","author":"Sessions","year":"1998"},{"key":"10.1111\/nure.12084-BIB0038|nure12084-cit-0038","first-page":"811","article-title":"Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins - a placebo-controlled and double blind study","volume":"50","author":"Richelsen","year":"1996","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0039|nure12084-cit-0039","first-page":"67","article-title":"One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels","volume":"106","author":"Hlivak","year":"2005","journal-title":"Bratisl Lek Listy."},{"key":"10.1111\/nure.12084-BIB0040|nure12084-cit-0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.ejcn.1602719","article-title":"Probiotic capsules do not lower plasma lipids in young women and men","volume":"62","author":"Greany","year":"2008","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0041|nure12084-cit-0041","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.ejcn.1601399","article-title":"Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol","volume":"56","author":"Kiessling","year":"2002","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0042|nure12084-cit-0042","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/07315724.2008.10719723","article-title":"Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids","volume":"27","author":"Hatakka","year":"2008","journal-title":"J Am Coll Nutr."},{"key":"10.1111\/nure.12084-BIB0043|nure12084-cit-0043","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.ejcn.1602139","article-title":"A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids","volume":"59","author":"Lewis","year":"2005","journal-title":"Eur J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0044|nure12084-cit-0044","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3168\/jds.S0022-0302(89)79439-X","article-title":"Lactobacillus effects on cholesterol: in vitro and in vivo results","volume":"72","author":"Lin","year":"1989","journal-title":"J Dairy Sci."},{"key":"10.1111\/nure.12084-BIB0045|nure12084-cit-0045","unstructured":"US Department of Health and Human Services, US Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologies Evaluation and Research (CBER) Guidance for industry: E9 statistical principles for clinical trials http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm073137.pdf"},{"key":"10.1111\/nure.12084-BIB0046|nure12084-cit-0046","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-2275(20)39588-2","article-title":"Catabolism and elimination of cholesterol in germfree rats","volume":"7","author":"Wostmann","year":"1966","journal-title":"J Lipid Res."},{"key":"10.1111\/nure.12084-BIB0047|nure12084-cit-0047","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-2275(20)43040-8","article-title":"Fecal neutral steroids and bile acids from germfree rats","volume":"10","author":"Kellogg","year":"1969","journal-title":"J Lipid Res."},{"key":"10.1111\/nure.12084-BIB0048|nure12084-cit-0048","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jn\/103.7.982","article-title":"Intestinal bile acids and cholesterol absorption in the germfree rat","volume":"103","author":"Wostmann","year":"1973","journal-title":"J Nutr."},{"key":"10.1111\/nure.12084-BIB0049|nure12084-cit-0049","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10409230290771519","article-title":"Effects of consumption of probiotics and prebiotics on serum lipid levels in humans","volume":"37","author":"Pereira","year":"2002","journal-title":"Crit Rev Biochem Mol Biol."},{"key":"10.1111\/nure.12084-BIB0050|nure12084-cit-0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1753-4887.2007.tb00309.x","article-title":"Probiotics: a critical review of their potential role as antihypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments","volume":"65","author":"Liong","year":"2007","journal-title":"Nutr Rev."},{"key":"10.1111\/nure.12084-BIB0051|nure12084-cit-0051","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1160\/TH10-08-0522","article-title":"Association of plasma fibrinogen, C-reactive protein and G-455>A polymorphism with early atherosclerosis in the VITA Project cohort","volume":"105","author":"Tosetto","year":"2011","journal-title":"Thromb Haemost."},{"key":"10.1111\/nure.12084-BIB0052|nure12084-cit-0052","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0733-8651(03)00079-1","article-title":"C-reactive protein, inflammation, and coronary risk","volume":"21","author":"Ridker","year":"2003","journal-title":"Cardiol Clin."},{"key":"10.1111\/nure.12084-BIB0053|nure12084-cit-0053","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation."},{"key":"10.1111\/nure.12084-BIB0054|nure12084-cit-0054","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1111\/nure.12084-BIB0055|nure12084-cit-0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/nu3060637","article-title":"Gut microbiota and inflammation","volume":"3","author":"Hakansson","year":"2011","journal-title":"Nutrients."},{"key":"10.1111\/nure.12084-BIB0056|nure12084-cit-0056","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plipres.2009.11.001","article-title":"Bile acid-activated receptors in the treatment of dyslipidemia and related disorders","volume":"49","author":"Fiorucci","year":"2010","journal-title":"Prog Lipid Res."},{"key":"10.1111\/nure.12084-BIB0057|nure12084-cit-0057","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","article-title":"The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation","volume":"54","author":"Pols","year":"2011","journal-title":"J Hepatol."},{"key":"10.1111\/nure.12084-BIB0058|nure12084-cit-0058","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem."},{"key":"10.1111\/nure.12084-BIB0059|nure12084-cit-0059","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab."},{"key":"10.1111\/nure.12084-BIB0060|nure12084-cit-0060","first-page":"579","article-title":"Counter-regulatory role of bile acid activated receptors in immunity and inflammation","volume":"10","author":"Fiorucci","year":"2010","journal-title":"Curr Mol Med."},{"key":"10.1111\/nure.12084-BIB0061|nure12084-cit-0061","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12223-008-0059-1","article-title":"Beneficial health effects of milk and fermented dairy products-review","volume":"53","author":"Ebringer","year":"2008","journal-title":"Folia Microbiol (Praha)."},{"key":"10.1111\/nure.12084-BIB0062|nure12084-cit-0062","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.290.4.502","article-title":"Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein","volume":"290","author":"Jenkins","year":"2003","journal-title":"JAMA."},{"key":"10.1111\/nure.12084-BIB0063|nure12084-cit-0063","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ajcn.83.3.582","article-title":"Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia","volume":"83","author":"Jenkins","year":"2006","journal-title":"Am J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0064|nure12084-cit-0064","unstructured":"US Food and Drug Administration, Department of Health and Human Services Health claims: plant sterol\/stanol esters and risk of coronary heart disease (CHD). 21C.F.R.101.83 http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=101.83"},{"key":"10.1111\/nure.12084-BIB0065|nure12084-cit-0065","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.2903\/j.efsa.2012.2693","article-title":"Scientific opinion on the substantiation of a health claim related to 3\u2009g\/day plant sterols\/stanols and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 19 of Regulation (EC) No 1924\/2006","volume":"10","author":"EFSA Panel on Dietetic Products Nutrition and Allergies (NDA)","year":"2012","journal-title":"EFSA J."},{"key":"10.1111\/nure.12084-BIB0066|nure12084-cit-0066","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0025-6196(11)63144-3","article-title":"Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels","volume":"78","author":"Katan","year":"2003","journal-title":"Mayo Clin Proc."},{"key":"10.1111\/nure.12084-BIB0067|nure12084-cit-0067","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/qjmed\/hcr007","article-title":"Role of phytosterols in lipid-lowering: current perspectives","volume":"104","author":"Gupta","year":"2011","journal-title":"QJM."},{"key":"10.1111\/nure.12084-BIB0068|nure12084-cit-0068","doi-asserted-by":"crossref","DOI":"10.3402\/fnr.v52i0.1811","article-title":"Plant sterols\/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials","volume":"52","author":"Abumweis","year":"2008","journal-title":"Food Nutr Res."},{"key":"10.1111\/nure.12084-BIB0069|nure12084-cit-0069","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ajcn\/71.2.472","article-title":"Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials","volume":"71","author":"Anderson","year":"2000","journal-title":"Am J Clin Nutr."},{"key":"10.1111\/nure.12084-BIB0070|nure12084-cit-0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1039\/c0fo00080a","article-title":"Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides","volume":"1","author":"Gunness","year":"2010","journal-title":"Food Funct."},{"key":"10.1111\/nure.12084-BIB0071|nure12084-cit-0071","unstructured":"US Food and Drug Administration, Department of Health and Human Services Health claims: soluble fibers from certain foods and risk of coronary heart disease (CHD) 21C.F.R.101.81. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/cfrsearch.cfm?fr=101.81"},{"key":"10.1111\/nure.12084-BIB0072|nure12084-cit-0072","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2903\/j.efsa.2010.1885","article-title":"Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) health disease pursuant to Article 14 of Regulation (EC) No 1924\/2006","volume":"8","author":"EFSA Panel on Dietetic Products Nutrition and Allergies (NDA)","year":"2010","journal-title":"EFSA J."},{"key":"10.1111\/nure.12084-BIB0073|nure12084-cit-0073","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2903\/j.efsa.2011.2470","article-title":"Scientific Opinion on the substantiation of a health claim related to barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924\/2006","volume":"9","author":"EFSA Panel on Dietetic Products Nutrition and Allergies (NDA)","year":"2011","journal-title":"EFSA J."},{"key":"10.1111\/nure.12084-BIB0074|nure12084-cit-0074","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.nut.2010.11.006","article-title":"Meta-analysis of the effect of beta-glucan intake on blood cholesterol and glucose levels","volume":"27","author":"Tiwari","year":"2011","journal-title":"Nutrition."},{"key":"10.1111\/nure.12084-BIB0075|nure12084-cit-0075","unstructured":"US Food and Drug Administration, Department of Health and Human Services Health claims: Soy protein and risk of coronary heart disease (CHD) 21C.F.R.101.82. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/cfrsearch.cfm?fr=101.82"},{"key":"10.1111\/nure.12084-BIB0076|nure12084-cit-0076","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/07315724.2011.10719947","article-title":"Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies","volume":"30","author":"Anderson","year":"2011","journal-title":"J Am Coll Nutr."},{"key":"10.1111\/nure.12084-BIB0077|nure12084-cit-0077","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacl.2010.07.001","article-title":"Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review","volume":"4","author":"Nijjar","year":"2010","journal-title":"J Clin Lipidol."},{"key":"10.1111\/nure.12084-BIB0078|nure12084-cit-0078","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol."},{"key":"10.1111\/nure.12084-BIB0079|nure12084-cit-0079","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)","volume":"81","author":"Jones","year":"1998","journal-title":"Am J Cardiol."},{"key":"10.1111\/nure.12084-BIB0080|nure12084-cit-0080","unstructured":"Micropharma Ltd Lactobacillus reuteri NCIMB 30242. GRAS Notice 2012 http:\/\/www.accessdata.fda.gov\/scripts\/fcn\/gras_notices\/GRN000440.pdf"},{"key":"10.1111\/nure.12084-BIB0081|nure12084-cit-0081","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/08910609509141381","article-title":"Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects","volume":"8","author":"Wolf","year":"1995","journal-title":"Microb Ecol Health Dis."},{"key":"10.1111\/nure.12084-BIB0082|nure12084-cit-0082","unstructured":"US Food and Drug Administration, CFSAN\/Office of Food Additive Safety 2008 http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/GRAS\/NoticeInventory\/ucm154990.htm"},{"key":"10.1111\/nure.12084-BIB0083|nure12084-cit-0083","unstructured":"Department of Health and Ageing, Therapeutic Goods Administration Substances that may be used in listed medicines in Australia http:\/\/www.tga.gov.au\/pdf\/cm-listed-substances.pdf"},{"key":"10.1111\/nure.12084-BIB0084|nure12084-cit-0084","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2903\/j.efsa.2009.1431","article-title":"Scientific Opinion on the maintenance of the list of QPS microorganisms intentionally added to food or feed (2009 update)","volume":"7","author":"EFSA Panel on Biological Hazards (BIOHAZ)","year":"2009","journal-title":"EFSA J."},{"key":"10.1111\/nure.12084-BIB0085|nure12084-cit-0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/07315724.2006.10719554","article-title":"Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: a pilot study","volume":"25","author":"Weizman","year":"2006","journal-title":"J Am Coll Nutr."},{"key":"10.1111\/nure.12084-BIB0086|nure12084-cit-0086","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01.mpg.0000176179.81638.45","article-title":"Safety of D(-)-lactic acid producing bacteria in the human infant","volume":"41","author":"Connolly","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1111\/nure.12084-BIB0087|nure12084-cit-0087","first-page":"1","article-title":"In vitro characterization and safety of the probiotic strain Lactobacillus reuteri cardioviva NCIMB 30242","volume":"6","author":"Branton","year":"2010","journal-title":"Int J Probiotics Prebiotics."},{"key":"10.1111\/nure.12084-BIB0088|nure12084-cit-0088","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yrtph.2012.04.003","article-title":"Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: a randomized control trial","volume":"63","author":"Jones","year":"2012","journal-title":"Regul Toxicol Pharmacol."},{"key":"10.1111\/nure.12084-BIB0089|nure12084-cit-0089","unstructured":"US Food and Drug Administration GRAS notice inventory. GRN no. 440 2012 http:\/\/www.accessdata.fda.gov\/scripts\/fcn\/fcnNavigation.cfm?rpt=grasListing&displayAll=false&page=1"},{"key":"10.1111\/nure.12084-BIB0090|nure12084-cit-0090","unstructured":"US Food and Drug Administration CFSAN\/Office of Food Additive Safety http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/GRAS\/NoticeInventory\/ucm153759.htm"},{"key":"10.1111\/nure.12084-BIB0091|nure12084-cit-0091","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijfoodmicro.2007.08.017","article-title":"Safety assessment of dairy microorganisms: the Enterococcus genus","volume":"126","author":"Ogier","year":"2008","journal-title":"Int J Food Microbiol."},{"key":"10.1111\/nure.12084-BIB0092|nure12084-cit-0092","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijfoodmicro.2011.08.014","article-title":"Enterococci as probiotics and their implications in food safety","volume":"151","author":"Franz","year":"2011","journal-title":"Int J Food Microbiol."},{"key":"10.1111\/nure.12084-BIB0093|nure12084-cit-0093","unstructured":"US Food and Drug Administration Draft guidance for industry: dietary supplements: new dietary ingredient notifications and related issues http:\/\/www.fda.gov\/food\/guidanceregulation\/guidancedocumentsregulatoryinformation\/dietarysupplements\/ucm257563.htm"}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/72\/1\/18\/5447211\/nutritionreviews72-0018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T18:54:32Z","timestamp":1647716072000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-lookup\/doi\/10.1111\/nure.12084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,13]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"URL":"https:\/\/doi.org\/10.1111\/nure.12084","relation":{},"ISSN":["0029-6643"],"issn-type":[{"value":"0029-6643","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12,13]]}}}